Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1854156 | Reports of Practical Oncology & Radiotherapy | 2015 | 8 Pages |
Abstract
A large body of evidence now exists to support the use of SBRT for early-stage NSCLC. Decisions regarding the optimal choice of treatment should be individualized, and made in the context of a multidisciplinary team.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Nuclear and High Energy Physics
Authors
Samer Chehade, David A. Palma,